Jianfeng Wen

Title: **Jianfeng Wen: A Pioneer in Pharmaceutical Innovation**

Introduction

Jianfeng Wen is a distinguished inventor based in Suzhou, China, recognized for his significant contributions to pharmaceutical chemistry. With a total of six patents to his name, he has developed innovative solutions that have the potential to impact cancer treatment and improve therapeutic outcomes.

Latest Patents

Among Jianfeng Wen's latest patents is a groundbreaking invention involving crystalline and amorphous forms of N-(phenyl sulfonyl) benzamide compounds or their salts or solvates. This invention serves as a Bcl-2 inhibitor, with an emphasis on its preparation methods and applications. Another notable patent details a process for producing alkynyl-containing compounds and their intermediates, particularly highlighting a compound designated as formula 6. This compound is integral to a pharmaceutical composition aimed at treating cancer.

Career Highlights

Throughout his career, Jianfeng Wen has made remarkable strides in the pharmaceutical industry. He has been affiliated with Ascentage Pharma (Suzhou) Co., Ltd. and Ascentage Pharma Group Corporation, where he has played a crucial role in advancing research and development efforts in the field of oncology.

Collaborations

Jianfeng Wen has collaborated with several talented individuals in the industry, including Ming Guo and Jianpeng Feng. These partnerships have fostered a dynamic research environment that promotes innovation and the development of novel therapeutics.

Conclusion

Jianfeng Wen's contributions to the field of pharmaceuticals exemplify the spirit of innovation and dedication to enhancing medical treatments. His work, particularly in cancer therapy, demonstrates the importance of continued research and development in improving patient outcomes. As he continues to innovate, Jianfeng Wen remains a key figure in the advancement of pharmaceutical science.